Works in Diabetes, Obesity & Metabolism, 2024, Vol 26, Issue 10


Results: 73
    1
    2

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. C1, doi. 10.1111/dom.15964
    By:
    • Escobar Vasco, Maria Adelaida;
    • Fantaye, Samuel H.;
    • Raghunathan, Sapna;
    • Solis‐Herrera, Carolina
    Publication type:
    Article
    3

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. C4, doi. 10.1111/dom.16055
    By:
    • Andersen, Grit;
    • Eloy, Rosy;
    • Heise, Tim;
    • Gaudier, Martin;
    • Mégret, Claire;
    • Seroussi, Cyril;
    • Chan, You‐Ping;
    • Soula, Olivier;
    • Riddle, Matthew;
    • DeVries, J. Hans
    Publication type:
    Article
    4
    5
    6
    7
    8

    The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4713, doi. 10.1111/dom.15840
    By:
    • Tsaban, Gal;
    • Aharon‐Hananel, Genya;
    • Shalem, Shiran;
    • Zelicha, Hila;
    • Yaskolka Meir, Anat;
    • Pachter, Dafna;
    • Goldberg, Dana Tamar;
    • Kamer, Omer;
    • Alufer, Liav;
    • Stampfer, Meir J.;
    • Wang, Dong D.;
    • Qi, Lu;
    • Blüher, Matthias;
    • Stumvoll, Michael;
    • Hu, Frank B.;
    • Shai, Iris;
    • Tirosh, Amir
    Publication type:
    Article
    9
    10
    11

    Periodontal tissue susceptibility to glycaemic control in type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4684, doi. 10.1111/dom.15835
    By:
    • Inoue, Moe;
    • Sakanaka, Akito;
    • Katakami, Naoto;
    • Furuno, Masahiro;
    • Nishizawa, Hitoshi;
    • Omori, Kazuo;
    • Taya, Naohiro;
    • Ishikawa, Asuka;
    • Mayumi, Shota;
    • Tanaka Isomura, Emiko;
    • Takeuchi, Hiroki;
    • Amano, Atsuo;
    • Shimomura, Iichiro;
    • Fukusaki, Eiichiro;
    • Kuboniwa, Masae
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    The dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 receptor agonist tirzepatide effects on body weight evolution, adiponectin, insulin and leptin levels in the combination of obesity, type 2 diabetes and menopause in mice

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4613, doi. 10.1111/dom.15820
    By:
    • Reis‐Barbosa, Pedro H.;
    • Marcondes‐de‐Castro, Ilitch;
    • Marinho, Thatiany S.;
    • Aguila, Marcia Barbosa;
    • Mandarim‐de‐Lacerda, Carlos A.
    Publication type:
    Article
    23

    Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4602, doi. 10.1111/dom.15817
    By:
    • Oulhaj, Abderrahim;
    • Aziz, Faisal;
    • Suliman, Abubaker;
    • Eller, Kathrin;
    • Bentoumi, Rachid;
    • Buse, John B.;
    • Al Mahmeed, Wael;
    • von Lewinski, Dirk;
    • Coleman, Ruth L.;
    • Holman, Rury R.;
    • Sourij, Harald
    Publication type:
    Article
    24
    25
    26
    27
    28

    Oxytocin does not acutely improve glucose tolerance in men with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4562, doi. 10.1111/dom.15812
    By:
    • Goll, Nina;
    • Moszka, Nina;
    • Kantartzis, Konstantinos;
    • Preissl, Hubert;
    • Gruber, Tim;
    • Fritsche, Louise;
    • Jumpertz‐von Schwarzenberg, Reiner;
    • García‐Cáceres, Cristina;
    • Fritsche, Andreas;
    • Hallschmid, Manfred
    Publication type:
    Article
    29
    30
    31

    Body weight change associated kidney outcomes of sodium–glucose cotransporter new users.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4535, doi. 10.1111/dom.15808
    By:
    • Jimba, Takahiro;
    • Kaneko, Hidehiro;
    • Azegami, Tatsuhiko;
    • Suzuki, Yuta;
    • Okada, Akira;
    • Ko, Toshiyuki;
    • Fujiu, Katsuhito;
    • Takeda, Norifumi;
    • Morita, Hiroyuki;
    • Hayashi, Kaori;
    • Nishiyama, Akira;
    • Node, Koichi;
    • Yasunaga, Hideo;
    • Takeda, Norihiko;
    • Nangaku, Masaomi;
    • Komuro, Issei
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4441, doi. 10.1111/dom.15798
    By:
    • Moura, Filipe A.;
    • Bellavia, Andrea;
    • Berg, David D.;
    • Melloni, Giorgio E. M.;
    • Feinberg, Mark W.;
    • Leiter, Lawrence A.;
    • Bohula, Erin A.;
    • Morrow, David A.;
    • Scirica, Benjamin A.;
    • Wiviott, Stephen D.;
    • Sabatine, Marc S.
    Publication type:
    Article
    41
    42

    The role of incretin receptor agonists in the treatment of obesity.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4178, doi. 10.1111/dom.15796
    By:
    • Forst, Thomas;
    • De Block, Christophe;
    • Del Prato, Stefano;
    • Armani, Sara;
    • Frias, Juan;
    • Lautenbach, Anne;
    • Ludvik, Bernhard;
    • Marinez, Marina;
    • Mathieu, Chantal;
    • Müller, Timo D.;
    • Schnell, Oliver
    Publication type:
    Article
    43
    44
    45

    Individual treatment effects of sodium‐glucose co‐transporter‐2 inhibitors on the risk of chronic kidney disease in patients with type 2 diabetes: A counterfactual prediction model based on real‐world data.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4418, doi. 10.1111/dom.15793
    By:
    • Siriyotha, Sukanya;
    • Lukkunaprasit, Thitiya;
    • Looareesuwan, Panu;
    • Kunakorntham, Patratorn;
    • Anothaisintawee, Thunyarat;
    • Nimitphong, Hataikarn;
    • McKay, Gareth J.;
    • Attia, John;
    • Thakkinstian, Ammarin
    Publication type:
    Article
    46
    47

    Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4767, doi. 10.1111/dom.15791
    By:
    • Piona, Claudia;
    • Passanisi, Stefano;
    • Bombaci, Bruno;
    • Marigliano, Marco;
    • Lombardo, Fortunato;
    • Mancioppi, Valentina;
    • Morandi, Anita;
    • Maffeis, Claudio;
    • Salzano, Giuseppina;
    • Grosso, Caterina;
    • Cherubini, Valentino;
    • Tiberi, Valentina;
    • Piccinno, Elvira;
    • Zecchino, Clara;
    • Maltoni, Giulio;
    • Zucchini, Stefano;
    • Reinstadler, Petra;
    • Felappi, Barbara;
    • Prandi, Elena;
    • Ripoli, Carlo
    Publication type:
    Article
    48
    49

    Barriers to early diagnosis of chronic kidney disease and use of sodium‐glucose cotransporter‐2 inhibitors for renal protection: A comprehensive review and call to action.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4165, doi. 10.1111/dom.15789
    By:
    • Czupryniak, Leszek;
    • Mosenzon, Ofri;
    • Rychlík, Ivan;
    • Clodi, Martin;
    • Ebrahimi, Fahim;
    • Janez, Andrej;
    • Kempler, Peter;
    • Małecki, Maciej;
    • Moshkovich, Evgeny;
    • Prázný, Martin;
    • Sourij, Harald;
    • Tankova, Tsvetalina;
    • Timar, Bogdan
    Publication type:
    Article
    50